• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于淀粉的“智能”纳米胶束:阿霉素的潜在递送系统。

Starch-based "smart" nanomicelles: Potential delivery systems for doxorubicin.

机构信息

Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, India.

Department of Chemistry, Uttaranchal University, Dehradun, India.

出版信息

Drug Dev Res. 2024 Sep;85(6):e22253. doi: 10.1002/ddr.22253.

DOI:10.1002/ddr.22253
PMID:39207174
Abstract

Vesicular nanosystems are a cornerstone to the contemporary drug delivery paradigm owing to their ability to encapsulate a variety of drug molecules, which improves the overall pharmacokinetics and bioavailability of the cargo drug. These systems have proven potential in the delivery of hydrophobic chemotherapeutic "Doxorubicin" (DOX), which faces frequent challenge relating to its nonspecific interactions, dose-limiting toxicity (myelosuppression being the most common manifestation), and short half-life (distribution half-life of 5 min, terminal half-life of 20-48 h), which limit its overall clinical effectiveness. "Smart" nanomicelles with stimuli-responsive linkages take advantage of tumor microenvironment for deploying the cargo drug at the target site, which prevents nonspecific distribution and, hence, low toxicity. Similarly, those with stealth properties evade protein response, which triggers the immunogenic response. The nanomicelles co-loaded with magnetic nanoparticles provide additional utility such as contrast enhancement agents in theranostics. Overall, the starch-based nanomicelles prove to be an excellent delivery system for overcoming the limitations associated with the conventional DOX delivery regime.

摘要

囊泡纳米系统是当代药物输送范式的基石,因为它们能够封装各种药物分子,从而改善了货物药物的整体药代动力学和生物利用度。这些系统在递送疏水性化疗药物“多柔比星”(DOX)方面具有巨大的潜力,DOX 面临着与其非特异性相互作用、剂量限制毒性(骨髓抑制是最常见的表现)和半衰期短(分布半衰期为 5 分钟,终末半衰期为 20-48 小时)相关的频繁挑战,这限制了其整体临床效果。具有刺激响应性连接的“智能”纳米胶束利用肿瘤微环境在靶部位释放货物药物,从而防止非特异性分布和因此产生的低毒性。同样,具有隐身特性的纳米胶束可以逃避触发免疫反应的蛋白反应。载有磁性纳米颗粒的纳米胶束还提供了附加功能,如治疗学中的造影增强剂。总体而言,基于淀粉的纳米胶束被证明是克服与传统 DOX 输送方案相关的局限性的优秀输送系统。

相似文献

1
Starch-based "smart" nanomicelles: Potential delivery systems for doxorubicin.基于淀粉的“智能”纳米胶束:阿霉素的潜在递送系统。
Drug Dev Res. 2024 Sep;85(6):e22253. doi: 10.1002/ddr.22253.
2
Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.叶酸修饰的双功能纳米载体靶向递送阿霉素
Mol Pharm. 2014 Nov 3;11(11):4164-78. doi: 10.1021/mp500389v. Epub 2014 Sep 29.
3
Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.基于具有 pH 响应性和还原敏感性接枝共聚物的核交联纳米胶束的简便制备及其用于阿霉素的递送。
Colloids Surf B Biointerfaces. 2018 Jan 1;161:606-613. doi: 10.1016/j.colsurfb.2017.11.038. Epub 2017 Nov 16.
4
Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells.用于将阿霉素和P-糖蛋白小干扰RNA共递送至MCF-7细胞的梳状两亲性多肽基共聚物纳米胶束
Mater Sci Eng C Mater Biol Appl. 2016 May;62:564-73. doi: 10.1016/j.msec.2016.02.007. Epub 2016 Feb 5.
5
Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.通过叶酸修饰的核壳纳米胶束共递送P-糖蛋白小干扰RNA和阿霉素逆转多药耐药性乳腺癌
Colloids Surf B Biointerfaces. 2016 Feb 1;138:60-9. doi: 10.1016/j.colsurfb.2015.11.041. Epub 2015 Nov 25.
6
PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.聚乙二醇-甘胆酸树状聚合物胶束用于阿霉素靶向递送至 B 细胞淋巴瘤。
J Control Release. 2011 Oct 30;155(2):272-81. doi: 10.1016/j.jconrel.2011.07.018. Epub 2011 Jul 19.
7
A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.采用 pH 敏感前药策略,将 DOX 和 TOS 共递送至 TPGS 纳米胶束中,用于肿瘤治疗。
Colloids Surf B Biointerfaces. 2019 Jan 1;173:346-355. doi: 10.1016/j.colsurfb.2018.10.012. Epub 2018 Oct 5.
8
Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.聚乙二醇外壳可脱落的 TAT 修饰的核交联纳米胶束:TAT 增强的细胞摄取和溶酶体 pH 触发的阿霉素释放。
Colloids Surf B Biointerfaces. 2020 Apr;188:110772. doi: 10.1016/j.colsurfb.2020.110772. Epub 2020 Jan 20.
9
Nanomicelle drug with acid-triggered doxorubicin release and enhanced cellular uptake ability based on mPEG-graft-poly(N-(2-aminoethyl)-L-aspartamide)-hexahydrophthalic acid copolymers.基于甲氧基聚乙二醇接枝聚(N-(2-氨基乙基)-L-天冬酰胺)-六氢邻苯二甲酸共聚物的具有酸触发阿霉素释放和增强细胞摄取能力的纳米胶束药物
J Biomater Appl. 2018 Jan;32(6):826-838. doi: 10.1177/0885328217741522. Epub 2017 Nov 13.
10
Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.基于胆汁酸的药物传递系统增强阿霉素包封:药物负载和释放中疏水性和离子相互作用的比较。
Mol Pharm. 2018 Mar 5;15(3):1266-1276. doi: 10.1021/acs.molpharmaceut.7b01091. Epub 2018 Feb 6.

引用本文的文献

1
Dehydrodiisoeugenol targets the PLK1-p53 axis to inhibit breast cancer cell cycle.脱氢二异丁香酚靶向PLK1-p53轴以抑制乳腺癌细胞周期。
Front Pharmacol. 2025 Feb 28;16:1545498. doi: 10.3389/fphar.2025.1545498. eCollection 2025.